180 related articles for article (PubMed ID: 30393066)
1. Targeted Delivery of Antigen to Activated CD169
Edgar LJ; Kawasaki N; Nycholat CM; Paulson JC
Cell Chem Biol; 2019 Jan; 26(1):131-136.e4. PubMed ID: 30393066
[TBL] [Abstract][Full Text] [Related]
2. Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8
van Dinther D; Veninga H; Iborra S; Borg EGF; Hoogterp L; Olesek K; Beijer MR; Schetters STT; Kalay H; Garcia-Vallejo JJ; Franken KL; Cham LB; Lang KS; van Kooyk Y; Sancho D; Crocker PR; den Haan JMM
Cell Rep; 2018 Feb; 22(6):1484-1495. PubMed ID: 29425504
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation.
Kawasaki N; Vela JL; Nycholat CM; Rademacher C; Khurana A; van Rooijen N; Crocker PR; Kronenberg M; Paulson JC
Proc Natl Acad Sci U S A; 2013 May; 110(19):7826-31. PubMed ID: 23610394
[TBL] [Abstract][Full Text] [Related]
4. Selective tumor antigen vaccine delivery to human CD169
Affandi AJ; Grabowska J; Olesek K; Lopez Venegas M; Barbaria A; Rodríguez E; Mulder PPG; Pijffers HJ; Ambrosini M; Kalay H; O'Toole T; Zwart ES; Kazemier G; Nazmi K; Bikker FJ; Stöckl J; van den Eertwegh AJM; de Gruijl TD; Storm G; van Kooyk Y; den Haan JMM
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27528-27539. PubMed ID: 33067394
[TBL] [Abstract][Full Text] [Related]
5. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma.
Ohnishi K; Komohara Y; Saito Y; Miyamoto Y; Watanabe M; Baba H; Takeya M
Cancer Sci; 2013 Sep; 104(9):1237-44. PubMed ID: 23734742
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma.
van Dinther D; Veninga H; Revet M; Hoogterp L; Olesek K; Grabowska J; Borg EGF; Kalay H; van Kooyk Y; den Haan JMM
Front Immunol; 2018; 9():1997. PubMed ID: 30237798
[TBL] [Abstract][Full Text] [Related]
7. Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169.
Chen WC; Kawasaki N; Nycholat CM; Han S; Pilotte J; Crocker PR; Paulson JC
PLoS One; 2012; 7(6):e39039. PubMed ID: 22723922
[TBL] [Abstract][Full Text] [Related]
8. CD169 Defines Activated CD14
Affandi AJ; Olesek K; Grabowska J; Nijen Twilhaar MK; Rodríguez E; Saris A; Zwart ES; Nossent EJ; Kalay H; de Kok M; Kazemier G; Stöckl J; van den Eertwegh AJM; de Gruijl TD; Garcia-Vallejo JJ; Storm G; van Kooyk Y; den Haan JMM
Front Immunol; 2021; 12():697840. PubMed ID: 34394090
[TBL] [Abstract][Full Text] [Related]
9. CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma.
Zhang Y; Li JQ; Jiang ZZ; Li L; Wu Y; Zheng L
J Pathol; 2016 Jun; 239(2):231-41. PubMed ID: 27174787
[TBL] [Abstract][Full Text] [Related]
10. Liposome induction of CD8
Grabowska J; Affandi AJ; van Dinther D; Nijen Twilhaar MK; Olesek K; Hoogterp L; Ambrosini M; Heijnen DAM; Klaase L; Hidalgo A; Asano K; Crocker PR; Storm G; van Kooyk Y; den Haan JMM
J Control Release; 2021 Mar; 331():309-320. PubMed ID: 33493613
[TBL] [Abstract][Full Text] [Related]
11. Optimization of Liposomes for Antigen Targeting to Splenic CD169
Nijen Twilhaar MK; Czentner L; Grabowska J; Affandi AJ; Lau CYJ; Olesek K; Kalay H; van Nostrum CF; van Kooyk Y; Storm G; Haan JMMD
Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33255564
[TBL] [Abstract][Full Text] [Related]
12. CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.
Asano T; Ohnishi K; Shiota T; Motoshima T; Sugiyama Y; Yatsuda J; Kamba T; Ishizaka K; Komohara Y
Cancer Sci; 2018 May; 109(5):1723-1730. PubMed ID: 29520898
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma.
Ohnishi K; Yamaguchi M; Erdenebaatar C; Saito F; Tashiro H; Katabuchi H; Takeya M; Komohara Y
Cancer Sci; 2016 Jun; 107(6):846-52. PubMed ID: 26991548
[TBL] [Abstract][Full Text] [Related]
14. Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responses.
Veninga H; Borg EG; Vreeman K; Taylor PR; Kalay H; van Kooyk Y; Kraal G; Martinez-Pomares L; den Haan JM
Eur J Immunol; 2015 Mar; 45(3):747-57. PubMed ID: 25487358
[TBL] [Abstract][Full Text] [Related]
15. CD169
Grabowska J; Lopez-Venegas MA; Affandi AJ; den Haan JMM
Front Immunol; 2018; 9():2472. PubMed ID: 30416504
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma.
Saito Y; Ohnishi K; Miyashita A; Nakahara S; Fujiwara Y; Horlad H; Motoshima T; Fukushima S; Jinnin M; Ihn H; Takeya M; Komohara Y
Cancer Immunol Res; 2015 Dec; 3(12):1356-63. PubMed ID: 26297710
[TBL] [Abstract][Full Text] [Related]
17. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.
Klechevsky E; Flamar AL; Cao Y; Blanck JP; Liu M; O'Bar A; Agouna-Deciat O; Klucar P; Thompson-Snipes L; Zurawski S; Reiter Y; Palucka AK; Zurawski G; Banchereau J
Blood; 2010 Sep; 116(10):1685-97. PubMed ID: 20530286
[TBL] [Abstract][Full Text] [Related]
18. CD169+ Subcapsular Macrophage Role in Antigen Adjuvant Activity.
Lisk C; Yuen R; Kuniholm J; Antos D; Reiser ML; Wetzler LM
Front Immunol; 2021; 12():624197. PubMed ID: 33815376
[TBL] [Abstract][Full Text] [Related]
19. A Protective Role for the Lectin CD169/Siglec-1 against a Pathogenic Murine Retrovirus.
Uchil PD; Pi R; Haugh KA; Ladinsky MS; Ventura JD; Barrett BS; Santiago ML; Bjorkman PJ; Kassiotis G; Sewald X; Mothes W
Cell Host Microbe; 2019 Jan; 25(1):87-100.e10. PubMed ID: 30595553
[TBL] [Abstract][Full Text] [Related]
20. Platelets interact with CD169
Grabowska J; Léopold V; Olesek K; Nijen Twilhaar MK; Affandi AJ; Brouwer MC; Jongerius I; Verschoor A; van Kooten C; van Kooyk Y; Storm G; van 't Veer C; den Haan JMM
Front Immunol; 2023; 14():1290272. PubMed ID: 38054006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
